US Patent 9382237 3,5-diaminopyrazole kinase inhibitors
Patent 9382237 was granted and assigned to Axikin Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 24, 2014
Date of Patent
July 5, 2016
Patent Applicant
Patent Application Number
14552226
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9382237 3,5-diaminopyrazole kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.